Resources & Insights

COVID-19: Update from PharPoint Research

As the situation with COVID-19 evolves, the PharPoint Research team is taking necessary precautions to ensure study operations continue uninterrupted. During this critical time in our industry, PharPoint remains fully dedicated, as always, to helping clients improve global health.

March 16, 2020
No Comments
Rare Disease Day 2020

This February 29th, PharPoint acknowledges Rare Disease Day. We are relentless in supporting clients so that they may advance rare disease research and the approval of breakthrough treatments.

February 27, 2020
No Comments
Industry News: COVID-19

Information regarding the novel coronavirus is rapidly evolving as scientists and public-health officials race to uncover important details on the spread and treatment of the virus. Explore PharPoint’s news roundup and learn more about our extensive infectious disease experience.

February 4, 2020
No Comments
Data Reconciliation in EDC Platforms | Ask a CRO

How do you perform non-eCRF data (ECG, Labs, PK) reconciliation in EDC platforms like Medrio? A PharPoint clinical trial expert answers as part of our #askaclinicaltrialexpert blog series.

January 9, 2020
No Comments
Choosing an EDC Provider | Ask a CRO

For our upcoming study, we know we want to use EDC—but there are so many options. How should we choose an EDC provider? As part of our Ask a Clinical Trial Expert blog series, a PharPoint clinical trial expert answers.

January 9, 2020
No Comments
Clinical Trial Study Rescue | Ask a CRO

We’re worried that the service providers working on our study are causing it to fall behind. Timelines are being missed due to slow enrollment and data quality is poor. What are our options? A member of the PharPoint leadership team discusses options for study rescues in this Ask a Clinical Trial Expert blog series post.

October 9, 2019
No Comments
Bridging the the gap between sponsors and service providers

What challenges exist between CROs and Sponsors—and is collaborative technology the answer, or something else?

October 9, 2019
No Comments
The benefits of employing a functional service provider for clinical data management
The Benefits of using an FSP for Data Management Services For years, pharmaceutical and biotechnology companies have employed the strategy of establishing preferred provider relationships in order to streamline the process of outsourcing clinical research studies. While the the sponsor may have experienced cost-savings, often the result of working with a single service provider was...
October 9, 2019
No Comments
Global clinical data management without global offices
DOes your upcoming global study need a data management cro with global offices? While there are times when the location of the CDM service provider may be a cost driving factor, this is seldom the case. If a sponsor is conducting a study in a remote part of the world where the Data Manager would...
October 9, 2019
No Comments
PharPoint expands European capabilities

RESEARCH TRIANGLE PARK, N.C. (June 1, 2016) — PharPoint Research, a U.S.-based contract research organization (CRO), today announced the expansion of their clinical trial management and consulting service capabilities into Europe. The extension provides PharPoint Research’s global drug development clients greater access to increasingly meaningful markets and increases their reach across the European continent. With rising…

October 9, 2019
No Comments